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Epidemiology 
Chronic venous disease (CVD), including varicose veins and chronic 
venous insufficiency (CVI), is an extremely common medical 
condition that has a significant impact on an individual’s health 
and the healthcare system.[1] Estimates of the prevalence of CVD 
vary because of differences in the classification or definition used, 
methods of evaluation, and geographical regions studied.
The most common estimates of the prevalence of varicose veins 
are between 5% and 30% in the adult population, but reports have 
ranged from <1% to >70%.[1] The prevalence of this condition is 
higher in developed, industrial countries than in underdeveloped 
countries. The San Valentino Vascular Screening Project conducted 
in Italy found a 7% prevalence of varicose veins in 30 000 subjects 
evaluated by clinical assessment and duplex ultrasound. The rate 
for the development of varicose veins may be estimated from the 
Framingham study, which reported an annual incidence of 2.6% in 
women and 1.9% in men.[2] 
The most serious consequences of CVI, i.e. venous ulcers, either 
active or healed, occur in about 1% of the adult population.[1]
CVD has a significant impact on healthcare resources. Millions 
of people seek medical attention annually for varicose veins because 
of the cosmetic appearance or associated symptoms. Although often 
underplayed, the cosmetic consequences may adversely affect an 
individual’s quality of life (QoL). An even greater socio-economic 
impact is seen with more advanced venous disease. Venous ulceration 
has dramatic consequences that impair an individual’s ability to 
engage in social and occupational activities, reduce QoL, and impose 
financial constraints. CVD has a significant financial impact on the 
healthcare system, with an estimated $3 billion per year being spent 
on the treatment of venous wounds in the USA.[3] In countries with 
developed healthcare systems, the cost of treating advanced venous 
disease accounts for 1 - 2% of the total healthcare budget. 
The estimated prevalence of venous disease in the USA is as 
follows: varicose veins (>20 million), swollen legs (6 million), skin 
changes (1 million), skin ulcers (500 000).
Clinical manifestations 
History and physical examination 
The most common signs and symptoms of venous disorders are 
related to telangiectases, reticular veins, and varicose veins. With 
progressive dilatation and tortuosity, varicose veins may become 
painful as a result of venous distention. These veins are also prone 
to the development of superficial thrombophlebitis, as well as 
occasional bleeding from superficial veins and thinning of the 
overlying skin. Common symptoms related to CVD seen by the 
vascular specialist are pain, swelling, and ulceration of the legs. 
The pain or discomfort of the affected leg is typically described as 
‘heaviness or aching’ aggravated by prolonged standing and relieved 
by elevation. Additionally, chronic obstruction of the deep venous 
system may lead to claudication with intense leg cramping during 
ambulation because of exertion-induced venous hypertension. 
Oedema often begins in the foot and ankle and extends up the leg, 
with progressive worsening during the day as fluid accumulates in a 
time-dependent manner. Oedema is thought to produce discomfort 
by increasing intracompartmental volume and pressure. Venous-
related skin changes may also develop, including hyperpigmentation 
in the perimalleolar region secondary to haemosiderin deposition, 
lipodermatosclerosis with scarring, thickening of the skin secondary 
to fibrosis in the dermis and subcutaneous fatty tissue, and atrophie 
blanche characterised by circular whitish and atrophic skin 
surrounded by dilated capillaries and hyperpigmentation. There is 
also an increased risk for the development of other skin problems 
such as eczematous dermatitis, cellulitis, and lymphangitis. Delayed 
healing of leg ulcers may occur and lead to protracted ulceration.[4]
A complete history, including a previous medical and surgical 
history, is important in evaluating the aetiology of oedema and 
ulcerations as possible manifestations of CVI. A previous history of 
deep venous thrombosis or phlebitis, use of anticoagulation therapy, 
unexplained transient unilateral oedema, or previous venous-related 
interventions favour a venous aetiology. Similarly, a family history 
of varicosities, leg ulcerations, or thrombotic disorders supports a 
venous problem.
The venous examination should include an evaluation in both the 
supine and upright positions to induce maximal venous distention. The 
surface of the skin is examined for irregularities or bulges suggesting 
the presence of varicose veins. The distribution of these often follows 
the course of the affected superficial veins with dilatation of their 
branches, and palpation may reveal tenderness. Other characteristic 
skin findings include hyperpigmentation, eczematous dermatitis, 
atrophie blanche, and lipodermatosclerosis. The oedema is typically 
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pitting, although before the development 
of overt oedema there may be calf fullness 
or increased limb girth; therefore both calf 
muscle consistency and limb girth should 
be assessed. The appearance of a fan-shaped 
pattern of numerous intradermal veins on 
the medial or lateral aspect of the foot 
or ankle, termed corona phlebectatica (or 
inframalleolar ankle flare), is thought to 
be an early sign of advanced disease. The 
presence of active or healed ulcerations 
indicates advanced disease. These lesions 
usually occur in the medial and occasionally 
in the lateral perimalleolar region at the site 
of major perforating veins and the greatest 
hydrostatic pressure.[4]
The examination for ulceration should 
include a detailed arterial evaluation and 
often a neurological assessment for sensory 
deficits. A normal pulse essentially excludes 
arterial insufficiency; however, an ankle-
brachial index may be necessary if pulses are 
masked by oedema. Diabetics often require a 
limited neurological sensory examination to 
assess for peripheral neuropathy. Suspicious 
ulcers of prolonged duration with features 
suggestive of a mixed aetiology should be 
biopsied to exclude malignancy.[4]
Differential diagnosis 
A number of other medical conditions may 
display clinical findings suggestive of CVD. 
First, acute venous problems such as deep 
venous thrombosis need to be excluded. 
Systemic causes of oedema need to be 
considered, such as heart failure, nephrosis, 
liver disease, endocrine disorders, or side-
effects of medications such as calcium channel 
blockers, non-steroidal anti-inflammatory 
drugs, and oral hypoglycaemic agents. Other 
regional considerations include a ruptured 
popliteal cyst, soft tissue haematoma or mass, 
chronic exertional compartment syndrome, 
gastrocnemius tear, or lymphoedema. 
Pigmentation and dermatosclerosis may be 
mimicked by disorders such as dermatitis, 
myxoedema, necrobiosis diabeticorum, 
conditions with increased intra-abdominal 
pressure, i.e. ascites, and even morbid 
obesity. Chronic ulceration may be seen with 
rterial insufficiency, arteriovenous fistulae, 
peripheral neuropathies, vasculitides, 
rheumatoid arthritis, blood dyscrasias, e.g. 
sickle cell disease, infections, pyoderma 
gangrenosum, malignancy, trauma, and 
numerous others.[4]
Non-invasive testing 
Venous duplex imaging 
A venous duplex reflux examination 
(Fig. 1) combines B-mode and colour-
flow imaging of the deep and superficial 
veins and pulsed Doppler assessment of 
the direction of flow. The standard venous 
duplex examination assesses for venous 
thrombosis or obstruction, as well as changes 
associated with chronic thrombotic disease. 
In the reflux portion of the examination, 
direction of flow is assessed with provocative 
manoeuvres, which may involve the 
Valsalva manoeuvre or augmenting flow 
with distal limb compression in the reverse 
Trendelenburg position. However, the 
severity of disease as determined by duplex 
imaging correlates weakly with clinical 
manifestations.[5] Despite such limitations, 
the venous duplex reflux examination is 
considered the mainstay of non-invasive 
evaluation of CVI. It provides information 
about the anatomical distribution involving 
the deep, superficial, and perforator venous 
systems – useful information to help guide 
therapy.
Computed tomography 
The development of high-resolution 
computed tomography (CT) with contrast 
enhancement has allowed extension of its 
use for the evaluation of venous disease 
(Fig. 2). The technique is most useful in 
the evaluation of centrally located veins 
and their surrounding structures to 
assess intrinsic obstruction or extrinsic 
compression. Optimal imaging of the venous 
system requires the use of intravenous 
contrast material with appropriate timing 
of image acquisition based on venous filling. 
Abnormalities in venous flow are depicted 
as filling defects and the correct technique is 
required to avoid artefacts with inadequate 
venous opacification. CT may be used to 




The initial management of CVD involves 
non-interventional measures to reduce 
symptoms and prevent the development of 
secondary complications and the progression 
of disease. Behavioural measures such as 
leg elevation to minimise oedema and 
structured weight loss programmes should 
be advocated. The use of compression 
stockings is the mainstay of medical 
management. If medical measures fail or 
provide an unsatisfactory response, further 
treatment should be considered. Specific 
treatment is based on the severity of the 
disease, with CEAP clinical classes 4 - 6 
Table 1. The severity grading of venous disease (international consensus) (CEAP)
Symptoms Clinical signs
C0 C1 C2 C3 C4 C5 C6
Heavy legs, 
pain in the legs, 









Trophic changes of 




Healed ulcer with 
trophic changes
Presence of one 
or more active 
venous leg 
ulcers, often with 
trophic changes
C0 - C6 = description of the progression of the disease on the basis of the clinical signs present; CEAP: C =  clinical signs; E = (a)etiological classification; A = anatomical distribution;  
P = patho-physiological dysfunction.
Fig. 1. Venous duplex is the cornerstone of initial 
venous diagnostic assessment.
Fig. 2. Volume-rendered 3D reconstruction 
images of computed tomography venography are 
useful adjuncts to asses the iliocaval anatomical 
segments in patients with advanced (C3 - C6) 
disease.
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often requiring more invasive treatment 
(Table 1). In addition, early treatment of 
CEAP class 3 can be instituted to prevent 
possible progression to advanced CVD 
classes.[6]
Compression therapy 
Compression stockings should be considered 
for CEAP classes 2 - 6. The objective is 
to provide graded external compression of 
the leg and oppose the hydrostatic forces 
of venous hypertension. A number of 
compression garments are available, including 
graded elastic compression stockings, 
paste gauze boots, layered bandaging, and 
adjustable layered compression. The 
use of compression bandaging (Fig. 3) 
and stockings is well established in the 
treatment of CVD.[7] Treatment with 
30 - 40  mmHg compression stockings 
results in significant improvement in pain, 
swelling, skin pigmentation, activity, and 
well-being if a compliance level of 70 - 
80% is achieved. In patients with venous 
ulcers, graded compression stockings and 
other compression bandaging modalities are 
effective in healing ulcers and preventing 
recurrences of ulceration.[7] With a 
structured regimen of compression therapy, 
93% of patients with ulcers can achieve 
complete healing at a mean of 5.3 months. 
Wound- and skincare 
In advanced CVD, skin integrity may be 
compromised, thus making it important to 
maintain the health of the skin to prevent skin 
breakdown and infection. The development 
of eczematous dermatitis may require 
treatment with topical steroids. With venous 
ulcers, controlling bacterial overgrowth 
with aggressive woundcare may facilitate 
wound healing. A variety of hydrocolloids 
and foam dressings are available to manage 
wound fluid drainage and maceration of 
adjacent skin. In the presence of an infected 
ulcer bed, silver-impregnated dressings 
have been effective in controlling infection 
and restoring tissue integrity. However, 
because specific evidence-based guidelines 
are lacking, there is significant variation in 
practice patterns of wound- and skincare 
management. 
Pharmacological therapy 
Four groups of drugs have been evaluated 
in the treatment of CVD: coumarins 
(benzo-2-pyrones), flavonoids (2-phenyl-
1,4-benzopyrones), saponosides (horse 
chestnut seed extracts), and other plant 
extracts. These drugs with venoactive 
properties are widely used in Europe 
but are not approved in the USA. The 
pharmacological action of venoactive 
drugs increases venous tone and reduces 
capillary permeability, although the 
precise mechanism of action of these drugs 
is not known. 
Other agents have been used in the 
treatment of advanced venous disease with 
ulceration. Several trials have suggested 
that pentoxifylline may improve healing 
rates of venous ulcers, but the magnitude 
of the effect appears to be small and its role 
in management of this condition is unclear.
[8] Although the use of other agents, such as 
aspirin and platelet-derived growth factor, 
in promoting the healing or preventing 
the recurrence of venous ulceration has 
been reported, no large randomised studies 
have been conducted. There are no data to 
support the use of aspirin in the prevention 
of thrombo-embolic events in CVD.
Exercise 
Abnormalities in calf and foot muscle 
pump function play a significant role in the 
pathophysiology of CVI. Graded exercise 
programmes have been used in an effort to 
rehabilitate the muscle pump and improve 




Venous sclerotherapy is the treatment used 
to obliterate telangiectases, reticular veins, 
varicose veins, and saphenous segments with 
reflux. This may be the primary treatment 
or used in conjunction with surgical 
procedures for the correction of CVD. A 
number of sclerosing agents are available, 
including a hypertonic solution of sodium 
chloride (23.4%); detergents such as sodium 
tetradecyl sulphate, polidocanol, and 
sodium morrhuate; and other agents such 
as sodium iodide and chromated glycerin. 
In general, for smaller diameter veins, the 
sclerosing agent needs to be diluted to avoid 
tissue inflammation and necrosis. Sclerosing 
agents such as polidocanol have been shown 
to be superior to normal saline in both 
obliterating incompetent varicose veins 
and improving venous haemodynamics at 
12 weeks.[9] In Europe, sclerotherapy with 
polidocanol foam under duplex ultrasound 
guidance has become standard treatment for 
intracutaneous telangiectases, subcutaneous 
varicose veins, transfascial perforating 
veins, and venous malformations (Fig. 4). 
A common complication of sclerotherapy 
is hyperpigmentation of the surrounding 
skin due to the deposition of haemosiderin. 
The complications of sclerotherapy may 
be minimised using techniques such as 
microthrombectomy, using multiple small 
incisions directly over the thrombosed 
varicosity to extrude the thrombus. 
Endovenous radiofrequency and 
laser ablation 
A recent advancement in the treatment of 
venous insufficiency is the use of thermal 
energy in the form of radiofrequency or laser 
treatment to obliterate veins. This technique 
is frequently used for saphenous vein reflux 
as an alternative to surgical stripping 
and for its tributaries as an alternative 
to phlebectomy. These radiofrequency 
techniques generate heat, which causes 
thermal injury to the vein wall and leads 
to thrombosis and eventually fibrosis. 
Although radiofrequency ablation is less 
Fig. 3. Multilayered compression bandaging. Fig. 4. Foam sclerotherapy.
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invasive than surgical stripping, potential 
complications include paraesthesia, 
superficial thrombophlebitis, deep venous 
thrombosis, pulmonary embolism, 
bruising, skin burns, and infection. Laser 
treatment with an 810 nm, a 940 nm, or 
a 980 nm diode has provided excellent 
results, with saphenous vein obliteration in 
93% of cases at 1 and 2 years and no deep 
venous thrombosis.[10] Both radiofrequency 
and laser treatment are performed with 
tumescent anaesthesia, usually a mixture of 
0.1% lidocaine in saline, to provide a heat 
sink, prevent skin burns and reduce pain. 
Several studies comparing endovenous 
ablation with conventional ligation and 
stripping found that the short-term efficacy 
and safety of ablation and surgery are 
comparable, although the surgical group 
had increased postoperative pain and 
bruising. Both treatments were equally 
efficaceous in eliminating great saphenous 
vein reflux, alleviating symptoms and signs 
of saphenous varicosities, and improving 
QoL. 
Endovascular therapy 
Endovascular therapy has become an 
increasingly important means of restoring 
outflow of the venous system and providing 
relief of obstruction. Approximately 10 - 30% 
of patients with severe CVI have a significant 
abnormality in venous outflow involving 
iliac vein segments, which contributes to 
persistent symptoms. Before endovascular 
therapy, iliac vein stenosis and obstruction 
causing CVI were treated with surgical 
procedures such as cross-femoral venous 
bypass or iliac vein reconstructions with 
prosthetic material. Because of the success 
of venous stenting, surgical venous bypass is 
performed infrequently. The patency of iliac 
vein stents (Fig. 5) appears to be good, with a 
primary patency rate of 75% at 3 years. Close 
follow-up is advocated to ensure that stent 
patency is maintained and early intervention 
is performed for in-stent restenosis, which 
occurs in 23% of patients.[11] 
Surgical management 
Surgical options should be considered in 
patients with CVD refractory to medical 
and less invasive therapy, including those 
with persistent discomfort and disability or 
non-healing venous ulcers despite maximal 
medical management effort. Invasive and 
surgical options may also be considered 
in patients who are unable to comply with 
compression therapy or have recurring 
varicose veins.
Saphenous vein stripping and 
venous phlebectomy 
Removal of the saphenous vein with high 
ligation of the saphenofemoral junction 
is considered durable and has been the 
surgical standard for superficial saphenous 
insufficiency in CEAP clinical classes 
2 - 6. In addition, large varicose clusters 
that communicate with the incompetent 
saphenous vein can be avulsed during 
the same procedure by stab phlebectomy. 
Transilluminated power phlebectomy 
(or TriVex) may also be used to remove 
clusters of varicosities with fewer incisions 
and decreased operative time. Ligation 
plus stripping of the great saphenous vein 
results in significant improvement in venous 
haemodynamics, may eliminate concomitant 
deep venous reflux, provides symptomatic 
relief, and assists in ulcer healing. In a 
study evaluating 500 patients with venous 
ulcer and reflux of the superficial and deep 
venous systems, randomisation to surgery 
(only on the superficial venous segments) 
plus compression therapy led to a reduction 
in ulcer recurrence at 12 months compared 
with compression alone (12% v. 28%).[12] This 
supports the additional benefit of correcting 
the incompetent superficial venous system 
for preventing ulcer recurrence.
References
1. Beebe-Dimmer JL, Pfeifer JR,  Engle  JS,  et al.  The epidemiology of 
chronic venous insufficiency and varicose veins.  Ann Epidemiol 
2005;15:175-184. [http://dx.doi.org/10.1016/j.annepidem.2004.05.015]
2. Brand FN, Dannenberg AL, Abbott RD, et al. The epidemiology 
of varicose veins: The Framingham Study.  Am J Prev 
Med 1988;4:96-101.
3. McGuckin  M,  Waterman  R,  Brooks  J,  et al.  Validation of 
venous leg ulcer guidelines in the United States and United 
Kingdom.  Am J Surg  2002;183:132-137. [http://dx.doi.
org/10.1016/S0002-9610(01)00856-X]
4. Eberhardt RT, Raffetto JD. Contemporary review in cardiovascular 
medicine. Chronic venous insufficiency. Circulation 2005;111:2398-
2409. [http://dx.doi.org/10.1161/01.CIR.0000164199.72440.08]
5. Neglen P, Egger JF, Olivier J, Raju S. Hemodynamic and clinical 
impact of ultrasound-derived venous reflux parameters. J Vasc 
Surg 2004;40:303-310.
6. Danielsson  G,  Norgren  L,  Jungbeck  C,  et al.  Global venous 
function correlates better than duplex derived reflux to 
clinical class in the evaluation of chronic venous disease.  Int 
Angiol 2003;22:177-181.
7. Cullum N, Nelson EA, Fletcher AW, et al. Compression 
for venous leg ulcers. Cochrane Database Syst Rev 
2000;3:CD000265.
8. Colgan  M-P,  Dormandy  JA,  Jones  PW,  et al.  Oxpentifylline 
treatment of venous ulcers of the leg. Br Med J 1990;300:972-
975. [http://dx.doi.org/10.1136/bmj.300.6730.972]
9. Kahle  B,  Leng  K.  Efficacy of sclerotherapy in varicose veins: 
Prospective, blinded, placebo-controlled study.  Dermatol 
Surg 2004;30:723-728. [http://dx.doi.org/10.1111/j.1524-4725.2004.30207.x]
10. Min  RJ,  Khilnani  N,  Zimmet  SE.  Endovenous laser 
treatment of saphenous vein reflux: Long-term results.  J 
Vasc Interv Radiol  2003;14:991-996. [http://dx.doi.org/10.1097/01.
RVI.0000082864.05622.E4]
11. Neglen P, Raju S. In-stent recurrent stenosis in stents placed in the 
lower extremity venous outflow tract. J Vasc Surg 2004;39:181-
188. [http://dx.doi.org/10.1016/S0741-5214(03)01028-0]
12. Barwell  JR,  Davies  CE,  Deacon  J,  et al.  Comparison of 
surgery and compression with compression alone in chronic 
venous ulceration (ESCHAR study): Randomized controlled 
trial.  Lancet  2004;363:1854-1859. [http://dx.doi.org/10.1016/
S0140-6736(04)16353-8]
Fig. 5. Left common iliac vein stenting.
